Consecutive lynestrenol and cross-sex hormone treatment in biological female adolescents with gender dysphoria: a retrospective analysis

Table 2 Summary of patient characteristics and side effects

Comorbidity	Education	Side effects
Psychiatric: 11/43 (25.6 %) Social problems: 7/43 (16.3 %) DSD: 0/43 (0 %)	ASO: 9/42 (21.4 %) TSO: 16/42 (38.1 %) BSO: 11/42 (26.2 %) BUSO: 4/42 (9.5 %) KSO: 2/42 (4.8 %)	Time	Metrorrhagia	Acne
		L0 L6m L12m L + T0 L + T6m L + T12m	– 19/39 (48.7 %) 5/28 (17.9 %) 4/25 (16.0 %) 5/22 (22.7 %) 4/16 (25.0 %)	6/41 (14.6 %) 10/39 (25.6 %) 8/28 (28.6 %) 6/25 (24.0 %) 13/22 (59.1 %) 6/16 (37.5 %)
Smoking	Alcohol	Time	Headache	Hot flushes	fatigue
No: 34/43 (79.1 %) Moderate: 9/43 (20.9 %) High: 0/43 (0 %)	No: 24/43 (55.8 %) Yes: 19/43 (44.2 %)	L L + T	5/41 (12.1 %) 0/25 (0 %)	4/41 (9.8 %) 0/25 (0 %)	3/41 (7.3 %) 2/25 (8 %)

Smoking: Moderate: 1 to 20 cigarettes a day, high: >20 cigarettes a day
ASO theoretical education, TSO technical education, BSO vocational training, BUSO school for children with learning difficulties, KSO art school, L lynestrenol monotherapy, L+T lynestrenol and testosterone esters combination therapy

ISSN: 2042-6410